The effect of age in the usage of alpha receptor blocker treatment in prostate patients.
Age was considered in the usage of alpha receptor blocker in the treatment of prostate patients. Ninety patients with prostatism were treated with alpha 1 receptor blockers (Doxazocin 4 mg/day) for 8 weeks. Before and after treatment, the patients in two groups according to their age, above and below 60 years, were evaluated using International Prostate Symptom Score (IPSS). The patients younger than 60 years of age had more significant relief compared to those older than 60 years of age.
Atan
A
A
Ankara Numune Hospital, 1st Urology Clinic, Turkey.
Başar
M M
MM
Yildiz
M
M
Akalin
Z
Z
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000367:Age Factors; D000368:Aged; D003627:Data Interpretation, Statistical; D017292:Doxazosin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000188:drug therapy*; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D017430:Prostate-Specific Antigen; D017292:Doxazosin